Cloxacillin Sodium

氯唑西林钠

Report date: 2022/05/16 12:12:38
NME

Base Information

Drug NameCloxacillin Sodium
Drug Alias Name氯苯唑青霉素cloxacillinumcloxacilina邻氯青霉素钠氯唑西林 +[8] 
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsStaphylococcal Infections
Approved Indications in ChinaStaphylococcal Infections
Original Approved Country/TerritoryCanada
Original Approved Date1963/12/31
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesChengdu First Pharmaceutical Co Ltd
Inactive CompaniesWyeth-Ayerst LaboratoriesBristol-Myers Squibb Company
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01CF02
Related LinksWikipediaDrugBankKEGG